Yes but on F all volume.I will get back into this company if and when they raise some more money at a steep discount to the current share price and once they reach full production levels.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025